Fingerprint
Dive into the research topics of 'Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma
Abhishek Maiti, Maryam Nemati-Shafaee, Pavlos Msaouel, Lance C Pagliaro, Eric Jonasch, Nizar M. Tannir, Amishi Y. Shah
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations